| |
CDC/HRSA Advisory Committee on HIV and
STD Prevention and Treatment
The
Secretary of the U.S. Department of Health
and Human Services, and by delegation,
the Administrator, Health Resources and
Services Administration (HRSA)
and the Director, Centers for Disease
Control and Prevention (CDC), are authorized
under Sections 301, 311, 317, and 318
of the Public Health Service Act, (42
U.S.C. 241, 42 U.S.C. 243, 42 U.S.C. 247b,
and 42 U.S.C. 247c as amended) to establish
the CDC/HRSA Advisory Committee on HIV
and STD Prevention and Treatment (CHACHSPT).
The Committee was chartered on November
25, 2002. To assist HRSA and CDC in carrying
out their responsibilities the CDC/HRSA
Advisory Committee on HIV and STD Prevention
and Treatment assesses HRSA's and CDC's
activities related to the HIV, AIDS, and
other STDs, and makes recommendations
for the future directions of HRSA's and
CDC's programs to prevent, control, and
treat STDs, HIV, and AIDS.
The CDC/HRSA Advisory Committee on HIV
and STD Prevention and Treatment advises
the HRSA Administrator and CDC Director
on activities related to prevention and
control of HIV/AIDS and other STDs, the
support of health care services to persons
living with HIV/AIDS, and education of
health professionals and the public about
HIV/AIDS and other STDs. The Committee
supports the Agencies' process of identifying
and responding to the prevention and health
service delivery needs of affected communities,
and the needs of individuals living with
or at risk for HIV and other STDs.
The CDC/HRSA Advisory Committee on HIV
and STD Prevention and Treatment was established
under Section 222 of the Public Health
Service Act, as amended, 42 USC 217a.
The Committee is governed by provisions
of Public Law 92-463, as amended (5 U.S.C.,
Appendix 2) which sets forth standards
for the formation and use of advisory
committees.
The merger of the Centers for Disease
Control and Prevention (CDC) Advisory
Committee for HIV and STD Prevention (ACHSP)
and the Health Resources and Services
Administration (HRSA) AIDS Advisory Committee
(HAAC) into the CDC/HRSA Advisory Committee
on HIV and STD Prevention and Treatment,
a single advisory body, was announced
by the U.S. Department of Health and Human
Services Secretary Tommy G. Thompson in
November 2002.
The
new Advisory Committee advises the Secretary,
CDC, and HRSA on the full range of issues
including objectives, strategies, policies
and priorities for HIV and STD prevention,
care and treatment efforts. This new Committee
encourages strong inter-agency collaboration
across the spectrum of prevention and
care.
The
new Advisory Committee meets approximately
twice per year and consists of 18 members
including 2 Co-Chairs, nominated by the
Secretary of HHS to serve two to four year
terms. The members are knowledgeable in
the fields of public health, epidemiology,
laboratory practice, immunology, infectious
diseases, drug abuse, behavioral science,
health education, and health care delivery,
State health programs, clinical care, preventive
health, medical education, health services
and clinical research, and health care financing.
|
